Cardio-Oncologie: étude Pilote évaluant la faisabilité, Utilité Concrète, Interdisciplinaire d'Une Unité Spécialisée
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 5,000
- 试验地点
- 1
- 主要终点
- Incidence of cardio-toxicty
研究概览
简要总结
Cardio-oncology is an emerging field. Most of the data available have been issued from either retrospective analysis, industry data or pharmacovigilance data. These data sources include a number of bias.
CONFUCIUS is a single tertiary centre prospective registry including all patients who have been referred for cardio-oncology assessemnt.
The objectives are to provide a comprehensive vue of cardoi-oncology, enable to detect early signals of cardiotoxicity and enhance ancillary projetcts aiming at specific populations (e.g., type of cancer) and/or drugs.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •referred to cardio-oncology
排除标准
- •refusal to participate
结局指标
主要结局
Incidence of cardio-toxicty
时间窗: 5 years
Number of patients with cardiotoxicity in a cohort of patients referred to a cardio-oncology clinic
次要结局
- Analysis of cardioprotective strategies(5 years)
- Analysis of underlying cardiovacsular profile(5 years)
- Cardiovascular outcomes(10 years)
- Behaviour(5 years)
- Metabolic(5 years)
- Oncology(5 years)
- Any advserse event(5 years)
- Analysis of arrhythmias(5 years)
- Precision medicine(5 years)
- Analysis of cardiotoxicity(5 years)
研究者
Mariana Mirabel
MD, PhD, Assosiate Professor
European Georges Pompidou Hospital
